Skip to content

Total debt at other companies

Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$1.99M-20.1%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$328K-59.1%
Eli Lilly logo
Eli LillyLLY
Johnson & Johnson logo
Johnson & JohnsonJNJ
Amgen logo
AmgenAMGN
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $2.89M.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s total debt?
Shattuck Labs, Inc. (STTK) reported total debt of $2.89M in Q1 2026.
How has Shattuck Labs, Inc.'s total debt changed year-over-year?
Shattuck Labs, Inc.'s total debt decreased by 9.5% year-over-year, from $3.19M to $2.89M.
What is the long-term trend for Shattuck Labs, Inc.'s total debt?
Over 4 years (2020 to 2025), Shattuck Labs, Inc.'s total debt has grown at a -1.2% compound annual growth rate (CAGR), from $2.54M to $2.42M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.